← Eichor
Condition: Acute Promyelocytic Leukemia With Pml Rara Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Acute Promyelocytic Leukemia With Pml Rara

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acut
Phase 2 · 5 location(s) · M.D. Anderson Cancer Center · NCT01409161PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed A
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT02390635Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Phase 3 · 12 location(s) · Quetzal Therapeutics · NCT07504458
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.